You are here: Industry Insights > financial results

News List

Happiness Biotech Announced Financial Results for Fiscal Year Ended March 31, 2021 prnasia
August 03, 2021
Happiness Biotech Group Limited, an innovative China-based nutraceutical and dietary supplements producer and e-commerce services provider, today announced its financial results for the fiscal year ended March 31, 2021.
Samsung Biologics Reports First Quarter 2021 Financial Results prnasia
April 28, 2021
Samsung Biologics, the world's leading contract development and manufacturing organization, today announced financial results for the first quarter of fiscal 2021.
Ajanta Pharma posts jump in consolidated PAT to Rs176.63 crores in Q3 FY2020-21 expresspharma
February 03, 2021
Ajanta Pharma has reported financial results for the period ended December 31, 2020.
China Biologic Reports Financial Results for the Third Quarter of 2020 prnasia
November 25, 2020
China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the third quarter of 2020.
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results prnasia
November 18, 2020
China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.
Innovent Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Progress prnasia
August 27, 2020
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced its fi
GSK reports revenue growth at 3 per cent in quarter financial results expresspharma
May 19, 2020
Board of Directors of the Company recommends a Dividend of Rs. 40 per equity share (including special dividend of Rs. 20 per equity share) for the 12 months period ended March 31, 2020.
Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results prnasia
April 15, 2020
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it is re-issuing its previous
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates prnasia
March 20, 2020
Zai Lab Limited, a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for the twelve months ended December 31, 2019 and corporate updates.
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 prnasia
March 12, 2020
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results f

Previous page 1 2 3 4 5 6 Next page